Heterogeneity of the Association of TICI2c/3 and good Clinical Outcomes with Strata of Other Baseline Characteristics Older age groups showed a trend towards decreasing beneficial effect of eTICI 2c/3 over eTICI 2b50/2b67 ( p for interaction = 0.08), adjusted odds ratios for each quartile were as follows (Fig. 3 ): ≤62 years aOR 2.19 (95% CI 1.14–4.27), 63–73 years aOR 1.97 (95% CI 1.06–3.71), 74–82 years aOR 1.77 (95% CI 0.95–3.33), >82 aOR 0.68 (95% CI 0.3–1.51).
← all excerpts
Heterogeneity of the Relative Benefits of TICI 2c/3 over TICI 2b50/2b67 : Are there Patients who are less Likely to Benefit?
1
—
—